Şerif Şentürk

4.1k total citations
38 papers, 1.2k citations indexed

About

Şerif Şentürk is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Şerif Şentürk has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Physiology. Recurrent topics in Şerif Şentürk's work include Telomeres, Telomerase, and Senescence (7 papers), Epigenetics and DNA Methylation (6 papers) and CRISPR and Genetic Engineering (5 papers). Şerif Şentürk is often cited by papers focused on Telomeres, Telomerase, and Senescence (7 papers), Epigenetics and DNA Methylation (6 papers) and CRISPR and Genetic Engineering (5 papers). Şerif Şentürk collaborates with scholars based in Türkiye, United States and France. Şerif Şentürk's co-authors include Mehmet Öztürk, Kamil Can Akçalı, Esra Erdal, Özge Gürsoy-Yüzügüllü, Haluk Yuzugullu, Raffaella Sordella, Debjani Pal, Nuri Öztürk, Nitin H. Shirole and Dawid G. Nowak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Şerif Şentürk

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şerif Şentürk Türkiye 16 796 295 246 150 125 38 1.2k
Masayuki Nagahashi Japan 14 503 0.6× 394 1.3× 287 1.2× 64 0.4× 56 0.4× 27 1.0k
Baochi Ou China 17 602 0.8× 403 1.4× 302 1.2× 39 0.3× 64 0.5× 26 1.1k
Yaqin He China 15 978 1.2× 459 1.6× 294 1.2× 98 0.7× 306 2.4× 22 1.5k
Le Li China 17 559 0.7× 301 1.0× 337 1.4× 47 0.3× 43 0.3× 46 1.0k
Russell Ericksen United States 14 523 0.7× 305 1.0× 271 1.1× 98 0.7× 23 0.2× 22 1.0k
Yongfu Zhao China 24 923 1.2× 261 0.9× 529 2.2× 40 0.3× 132 1.1× 60 1.5k
Cynthia Kosinski United States 9 695 0.9× 427 1.4× 156 0.6× 61 0.4× 30 0.2× 9 1.2k

Countries citing papers authored by Şerif Şentürk

Since Specialization
Citations

This map shows the geographic impact of Şerif Şentürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şerif Şentürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şerif Şentürk more than expected).

Fields of papers citing papers by Şerif Şentürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şerif Şentürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şerif Şentürk. The network helps show where Şerif Şentürk may publish in the future.

Co-authorship network of co-authors of Şerif Şentürk

This figure shows the co-authorship network connecting the top 25 collaborators of Şerif Şentürk. A scholar is included among the top collaborators of Şerif Şentürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şerif Şentürk. Şerif Şentürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çetintaş, Vildan Bozok, et al.. (2025). The G protein‐coupled receptor GPR 89 A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells. FEBS Journal. 292(14). 3755–3770. 1 indexed citations
2.
3.
Karakülah, Gökhan, et al.. (2025). Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma. Cell Death and Disease. 16(1). 241–241. 2 indexed citations
4.
Şentürk, Şerif, et al.. (2024). The Therapeutic Effects of Bioactive Compounds on Colorectal Cancer via PI3K/Akt/mTOR Signaling Pathway: A Critical Review. Food Science & Nutrition. 12(12). 9951–9973. 5 indexed citations
5.
Şentürk, Şerif, et al.. (2024). Leveraging Circular Polymerization and Extension Cloning (CPEC) Method for Construction of CRISPR Screening Libraries. BIO-PROTOCOL. 15(1365). e5183–e5183. 1 indexed citations
6.
Şentürk, Şerif, et al.. (2023). Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines. Cells. 12(6). 836–836. 2 indexed citations
7.
Şentürk, Şerif, et al.. (2023). The paracaspase MALT1 is a downstream target of Smad3 and potentiates the crosstalk between TGF-β and NF-kB signaling pathways in cancer cells. Cellular Signalling. 105. 110611–110611. 8 indexed citations
8.
Şentürk, Şerif, et al.. (2023). MALT1 paracaspase is overexpressed in hepatocellular carcinoma and promotes cancer cell survival and growth. Life Sciences. 323. 121690–121690. 6 indexed citations
9.
Bulut, Esra, Şerif Şentürk, & Hülya Ayar Kayalı. (2023). Wild-type IDH1 Knockout Leads to G0/G1 Arrest, Impairs Cancer Cell Proliferation, Altering Glycolysis, and the TCA Cycle in Colon Cancer. Biochemical Genetics. 61(4). 1470–1486. 1 indexed citations
10.
11.
Pal, Debjani, Trine Lindsted, Ingrid Ibarra, et al.. (2021). An epigenetic switch regulates the ontogeny of AXL-positive/EGFR-TKi-resistant cells by modulating miR-335 expression. eLife. 10. 9 indexed citations
12.
Öztürk, Mehmet, et al.. (2021). Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines. Journal of Gastrointestinal Cancer. 52(4). 1320–1335. 4 indexed citations
13.
Özhan, Günes, et al.. (2021). Changes in Wnt and TGF-β Signaling Mediate the Development of Regorafenib Resistance in Hepatocellular Carcinoma Cell Line HuH7. Frontiers in Cell and Developmental Biology. 9. 639779–639779. 35 indexed citations
14.
Akbari, Soheil, Nur Arslan, Şerif Şentürk, & Esra Erdal. (2019). Next-Generation Liver Medicine Using Organoid Models. Frontiers in Cell and Developmental Biology. 7. 345–345. 55 indexed citations
15.
Şentürk, Şerif, Nitin H. Shirole, Dawid G. Nowak, et al.. (2017). Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization. Nature Communications. 8(1). 14370–14370. 133 indexed citations
16.
Nowak, Dawid G., Hyejin Cho, Tali Herzka, et al.. (2015). MYC Drives Pten/Trp53 -Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2. Cancer Discovery. 5(6). 636–651. 64 indexed citations
17.
Mender, İlgen, Şerif Şentürk, Kamil Can Akçalı, et al.. (2013). Imetelstat (a telomerase antagonist) exerts off-target effects on the cytoskeleton. International Journal of Oncology. 42(5). 1709–1715. 24 indexed citations
18.
Baǧışlar, Sevgi, Haluk Yuzugullu, Şerif Şentürk, et al.. (2010). The Ability to Generate Senescent Progeny as a Mechanism Underlying Breast Cancer Cell Heterogeneity. PLoS ONE. 5(6). e11288–e11288. 19 indexed citations
19.
Yuzugullu, Haluk, Khemais Benhaj, Nuri Öztürk, et al.. (2009). Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Molecular Cancer. 8(1). 90–90. 173 indexed citations
20.
Öztürk, Mehmet, Ayça Arslan-Ergül, Sevgi Baǧışlar, Şerif Şentürk, & Haluk Yuzugullu. (2008). Senescence and immortality in hepatocellular carcinoma. Cancer Letters. 286(1). 103–113. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Nagahashi Breakdown of academic impact, for papers by Baochi Ou Breakdown of academic impact, for papers by Yaqin He Breakdown of academic impact, for papers by Le Li Breakdown of academic impact, for papers by Russell Ericksen Breakdown of academic impact, for papers by Yongfu Zhao Breakdown of academic impact, for papers by Cynthia Kosinski
Rankless by CCL
2026